Lung cancer risk models come of age

Cancer Prevention Research

Volumn 1, Issue 4, 2008, Pages 226-228

  Field, John K ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CANCER DIAGNOSIS; CARCINOMA; HUMAN; LUNG TUMOR; MASS SCREENING; METHODOLOGY; NOTE; RISK; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THEORETICAL MODEL; VALIDATION STUDY;

ALGORITHMS; CARCINOMA; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MODELS, THEORETICAL; RISK; TOMOGRAPHY, SPIRAL COMPUTED; VALIDATION STUDIES AS TOPIC;

EID: 61549118830     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0144     Document Type: Review

References (30)

1. Hirsch F, Lippman S. Advances in the biology of lung cancer chemoprevention. J Clin Oncol 2005; 23:3186-97.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55: 74-108.
3. Schiller J, Harrington D, Belani C, et al; Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced nonsmall- cell lung cancer. N Engl J Med 2002;346: 92-8.
4. van Rens MT, de la Riviere AB, Elbers HR, van den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, IIIA. Chest 2000;117:374-9.
5. Ganti AK, Mulshine JL Lung cancer screening: panacea or pipe dream? Ann Oncol 2005;16 Suppl 2: ii215-9.
6. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74.
7. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med 2005;352:2714-20.
8. Field J, Duffy S. Lung cancer screening: the way forward. Br J Cancer. In press.
9. Institute NC. The nation's investment in cancer research. A plan and budget proposal for the year 2006. Available from: http://plan.cancer.gov/; 2006.
10. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.
11. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
12. Freedman AN, Seminara D, Gail MH, et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 2005;97:715-23.
13. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
14. Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 2000;11:477-88.
15. de Torres J, Bastarrika G, Wisnivesky J, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007;132:1932-8.
16. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26.
17. Cassidy A, Myles J, van-Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6.
18. Spitz M, Etzel C, Dong Q, Wei CQW, Hong W. An expanded risk prediction model of lung cancer. Cancer Prev Res. In press.
19. Etzel C, Kachroo S, Liu M, et al. Development and validation of a lung cancer risk prediction model for African Americans. Cancer Prev Res. In press.
20. Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-72.
21. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007;67:3493-5.
22. Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006;98:1215-26.
23. Pinsky PF, Ford M, Gamito E, et al. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Med Assoc 2008;100:291-8.
24. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002;20:911-20.
25. Nitadori J, Inoue M, Iwasaki M, et al. Association between lung cancer incidence and family history of lung cancer: data from a large-scale populationbased cohort study, the JPHC study. Chest 2006; 130:968-75.
26. Ashton M, Mimnagh C, Forrest D, Field JK. A pilot study to explore lung cancer early detection and clinical intervention in a primary care setting in Knowsley, Merseyside. J Thorac Oncol 2008;3:S27.
27. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7.
28. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-22.
29. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-42.
30. Cassidy A, Myles JP, Liloglou T, Duffy SW, Field JK. Defining high-risk individuals in a populationbased molecular-epidemiological study of lung cancer. Int J Oncol 2006;28:1295-301.